Link: https://www.bmsremspatientsafety.com/
Description: WebPrescribers: The Prescriber Portal for Bristol Myers Squibb-administered REMS Programs can be accessed by clicking on the below button. Please enter your User Name and Password to manage your patients.
DA: 6 PA: 38 MOZ Rank: 45
Link: https://www.bmsremspatientsafety.com/prescriber/login
Description: WebPrescriber Login. To login to your account: User Name. Password. Forgot Password?
DA: 31 PA: 85 MOZ Rank: 43
Link: https://www.bmsremspatientsafety.com/prescriber/patientSurvey?action=patientSurvey
Description: WebStarting June 15, 2020, Thalidomide REMS will replace THALOMID REMS and be used to complete REMS activities. THALOMID REMS prescribers and patients will be able to participate in the Thalidomide REMS without further action. Certified pharmacies will be contacted for training. Please contact Thalidomide REMS at 1-888-423-5436 with any …
DA: 71 PA: 30 MOZ Rank: 68
Link: https://www.celgene.com/rems-pharmacy-network/celgene-rems/
Description: WebCelgene has three products with REMS programs that also include ETASU: Revlimid® (lenalidomide), Pomalyst® (pomalidomide) and Thalomid® (thalidomide). The goals of these REMS are to prevent the risk of embryo exposure to Revlimid, Pomalyst, and Thalomid and to inform prescribers, patients, and pharmacists on the serious risks and safe-use ...
DA: 94 PA: 82 MOZ Rank: 76
Link: https://www.lenalidomiderems.com/
Description: WebTo avoid embryo-fetal exposure, lenalidomide is only available under a restricted distribution program called “Lenalidomide REMS”. Only prescribers and pharmacies certified by Lenalidomide REMS can prescribe and dispense lenalidomide to patients who are enrolled and meet all the conditions of Lenalidomide REMS.
DA: 25 PA: 92 MOZ Rank: 71
Link: https://www.bms.com/patient-and-caregivers/risk-evaluation-and-mitigation-strategies-rems.html
Description: WebBristol Myers Squibb administers three legacy Celgene REMS programs that also include ETASU: Lenalidomide REMS (including REVLIMID ® and generic lenalidomide), POMALYST REMS ® and THALOMID REMS ® . The goals of these REMS are to prevent the risk of embryo exposure to lenalidomide, Pomalyst (pomalidomide) and Thalomid (thalidomide) and to ...
DA: 91 PA: 93 MOZ Rank: 73
Link: https://www.pomalystrems.com/
Description: WebTo prevent the risk of embryo-fetal exposure to POMALYST. To inform prescribers, patients, and pharmacists on the serious risks and safe-use conditions for POMALYST. For additional information about the POMALYST REMS program, please contact the REMS Call Center at 1-888-423-5436.
DA: 38 PA: 74 MOZ Rank: 12
Link: https://www.lenalidomiderems.com/patient-resources/index.html
Description: WebYour doctor will enroll you in Lenalidomide REMS so that you can receive your medication. Use the materials below to learn more about Lenalidomide REMS and what you need to do. Patient Guide to
DA: 45 PA: 84 MOZ Rank: 7
Link: https://www.japha.org/article/S1544-3191(19)30208-0/fulltext
Description: WebMay 2, 2019 · The Celgene REMS Pharmacy Portal is an innovative online secure web portal (www.CelgeneREMSPharmacyPortal.com) with special access codes provided to pharmacies in the Celgene REMS restricted distribution network. The portal enables the pharmacies to obtain multiple dispense confirmation numbers and to review the status of authorization …
DA: 39 PA: 20 MOZ Rank: 31
Link: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/ipledge-risk-evaluation-and-mitigation-strategy-rems
Description: WebJan 14, 2022 · This tool is intended to allow prescribers and designees to send login links directly to their patients’ desired email address through the Manage Patients page of the iPLEDGE REMS portal.
DA: 58 PA: 71 MOZ Rank: 45